Zoetis Inc.
NYSEZoetis delivered Q2 numbers that beat organic revenue expectations yet sent the stock down another 6% on the week — the contradiction between reported results and market reaction is the clearest signal of how thoroughly investor confidence has eroded. The post-earnings move tells a stark story. The stock closed Friday at $72.66, down nearly 6% on both the day and the week, after Q2…
ZTS short interest tumbles 21.3% in one week to 2.93% of float, marking sharpest decline in months as covering accelerates.
Zoetis delivered Q2 numbers that beat organic revenue expectations yet sent the stock down another 6% on the week — the contradiction between reported results and market reaction is the clearest signal of how…
Zoetis heads into its August 5 earnings release having lost more than a third of its value this year, with the Street's conviction in its recovery sharply divided. The most telling pre-print signal is the relentless…
Snapshot as of 20 Sept 2026
Zoetis heads into its August 5 earnings report with options traders growing more defensive, short sellers rebuilding positions, and Morgan Stanley trimming its target — all on the same day. The sharpest new development…
Options traders and short sellers are converging on ZTS from multiple angles. The stock has dropped 4.3% over the past month. Earnings land on August 5. The loudest signal here is the relentless analyst price-target…
Zoetis enters the second half of 2026 with a rare alignment of signals pointing in the same direction: the stock is falling, short sellers are building, and analysts are cutting targets with unusual consistency. The…
ZTS is drifting near the floor of its post-earnings collapse, and the question this week is whether the analyst community has finished cutting or has more room to go. The stock closed at $76.39 on June 2, down nearly…
ZTS enters the final stretch of May with a clear internal vs. external disconnect. Three directors stepped in to buy shares at post-earnings lows in mid-May — yet the Street spent the same weeks racing to slash price…
ZTS heads into its May 20 Q1 earnings report already carrying one of the most dramatic selloffs in its recent history — and the company's own board members are putting money on the line. Three Zoetis directors bought…
ZTS enters the week after the most bruising single session it has seen in years. The stock closed at $82.83 on May 8, down 27% on the week and 29% over the past month — a collapse that followed Q1 results reported on…
Zoetis heads into its May 7 Q1 results with options traders markedly more defensive than they have been all year. The sharpest shift is in options positioning. The put/call ratio has climbed to 0.59, almost two…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZTS — free to start on ORTEX.
Sign up for free →Open ZTS on ORTEX